| [1] |
Ye Z, Zeng G, Huan Y, et al. The Status and Characteristics of Urinary Stone Composition in China[J]. BJU Int, 2019.
|
| [2] |
Pearle MS, Goldfarb DS, Assimos DG, et al. Medical management of kidney stones: AUA guideline[J]. J Urol, 2014. 192(2): 316-324.
|
| [3] |
罗敏, 苟淼, 沈鹏飞, 等. 代谢综合征与泌尿系结石的危险因素及结石成分的关系[J]. 四川医学, 2018, 39(2): 138-141.
|
| [4] |
Moreira DM, Friedlander JI, Hartman C, et al. Using 24-hour urinalysis to predict stone type[J]. J Urol, 2013. 190(6): 2106-2111.
|
| [5] |
Moreira DM, Friedlander JI, Carons A, et al. Association of serum biochemical metabolic panel with stone composition[J]. Int J Urol, 2015. 22(2): 195-199.
|
| [6] |
Otto BJ, Bozorgmehri S, Kuo J, et al. Age, Body mass index, and gender predict 24-hour urine parameters in recurrent idiopathic calcium oxalate stone formers[J]. J Endourol, 2017. 31(12): 1335-1341.
|
| [7] |
Kidd AC, McGettrick M, Tsim S, et al. Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors[J]. BMJ Open Respir Res, 2018, 5(1): e000240.
|
| [8] |
Knoll T, Schubert AB, Fahlenkamp D, et al. Urolithiasis through the ages: data on more than 200,000 urinary stone analyses[J]. J Urol, 2011, 185(4): 1304-1311.
|
| [9] |
Trinchieri A, Esposito N, Castelnuovo C, Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate[J]. Arch Ital Urol Androl, 2009, 81(3): 188-191.
|
| [10] |
Imamura Y, Kawamura K, Sazuka T, et al. Development of a nomogram for predicting the stone-free rate after transurethral ureterolithotripsy using semi-rigid ureteroscope[J]. Int J Urol, 2013, 20(6): 616-621.
|
| [11] |
Khan SR. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations[J]. J Urol, 2013, 189(3): 803-811.
|
| [12] |
Jairath A, Parekh N, Otano N, et al. Oxalobacter formigenes: Opening the door to probiotic therapy for the treatment of hyperoxaluria[J]. Scand J Urol, 2015, 49(4): 334-337.
|
| [13] |
Kim SC, Burns EK, Lingeman JE, et al. Cystine calculi: correlation of CT-visible structure, CT number, and stone morphology with fragmentation by shock wave lithotripsy[J]. Urol Res, 2007. 35(6): 319-324.
|
| [14] |
Alan C, Kocoglu H, Kosar S, et al. Role of twinkling artifact in characterization of urinary calculi[J]. Actas Urol Esp, 2011, 35(7): 396-402.
|
| [15] |
Hassani H, Raynal G, Spie R, et al. Imaging-based assessment of the mineral composition of urinary stones: an in vitro study of the combination of hounsfield unit measurement in noncontrast helical computerized tomography and the twinkling artifact in color doppler ultrasound[J]. Ultrasound Med Biol, 2012, 38(5): 803-810.
|
| [16] |
Shang M, Sun X, Liu Q, et al. Quantitative evaluation of the effects of urinary stone composition and size on color doppler twinkling artifact: a phantom study[J]. J Ultrasound Med, 2017, 36(4): 733-740.
|
| [17] |
Wisenbaugh ES, Paden RG, Silva AC, et al. Dual-energy vs conventional computed tomography in determining stone composition[J]. Urology, 2014, 83(6): 1243-1247.
|
| [18] |
Marchini G S, Remer E M, Gebreselassie S, et al. Stone characteristics on noncontrast computed tomography: establishing definitive patterns to discriminate calcium and uric acid compositions[J]. Urology, 2013. 82(3): 539-46.
|
| [19] |
Hughes P, The CARI guidelines. Kidney stones epidemiology[J]. Nephrology (Carlton), 2007, 12 Suppl 1: S26-30.
|
| [20] |
颜赟坤, 柳建军, 郑土康, 等. 粤西湛江地区285例泌尿系结石成分分析[J]. 中国医药科学, 2018,8(2): 176-179.
|
| [21] |
Barbera M, Tsirgiotis A, Barbera M, et al. The importance of citrates in treatment and prophylaxis of calcium oxalate urinary stones[J]. Arch Ital Urol Androl, 2016,88(4): 343-344.
|
| [22] |
McCormack M, Dessureault J, Guitard M, The urine specific gravity dipstick: a useful tool to increase fluid intake in stone forming patients[J]. J Urol, 1991, 146(6): 1475-1477.
|
| [23] |
Walker V, Stansbridge E M, Griffin D G, Demography and biochemistry of 2800 patients from a renal stones clinic[J]. Ann Clin Biochem, 2013, 50(Pt 2): 127-139.
|
| [24] |
Perinpam M, Ware EB, Smith JA, et al. Effect of Demographics on Excretion of Key Urinary Factors Related to Kidney Stone Risk[J]. Urology, 2015, 86(4): 690-696.
|
| [25] |
Lieske J C, Pena de la Vega L S, Slezak J M, et al. Renal stone epidemiology in Rochester, Minnesota: an update[J]. Kidney Int, 2006, 69(4): 760-764.
|
| [26] |
米华,邓耀良, 中国尿石症的流行病学特征[J]. 中华泌尿外科杂志, 2003(10): 66-67.
|
| [27] |
Krambeck AE, Khan NF, Jackson ME, et al. Inaccurate reporting of mineral composition by commercial stone analysis laboratories: implications for infection and metabolic stones[J]. J Urol, 2010, 184(4): 1543-1549.
|
| [28] |
Masterson JH, Woo JR, Chang DC, et al. Dyslipidemia is associated with an increased risk of nephrolithiasis[J]. Urolithiasis, 2015, 43(1): 49-53.
|
| [29] |
Torricelli FC, De SK, Gebreselassie S, et al. Dyslipidemia and kidney stone risk[J]. J Urol, 2014, 191(3): 667-672.
|
| [30] |
Khorami MH, Hashemi R, Bagherian-Sararoudi R, et al. The assessment of 24 24-h urine volume by measurement of urine specific gravity with dipstick in adults with nephrolithiasis[J]. Adv Biomed Res, 2012,1: 86.
|